Futura Medical Share Price (FUM)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Futura Medical Plc	LSE:FUM	London	Ordinary Share	GB0033278473	ORD 0.2P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.50	1.82%	28.00	7,571	08:00:55

Bid Price		Offer Price	High Price	Low Price	Open Price
27.00		29.00	28.00	27.50	27.50

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology		-7.24	-4.46		57

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
08:00:34	O	3,571	27.8899	GBX

Related Shares
Astrazeneca (AZN), Glaxosmithkline (GSK), Geiger Counter (GCS), Valirx (VAL)

Futura Medical (FUM) Latest News

Futura Medical News

Date	Time	Source	Headline
15/10/2019	17:44	RNSNON	Futura Medical PLC Futura Medical to Present Data on MED2005 at SMSNA
15/10/2019	17:42	UKREG	Futura Medical PLC Director / PCA Shareholding
18/9/2019	17:42	UKREG	Futura Medical PLC Director/PDMR Shareholding
16/9/2019	10:11	UKREG	Futura Medical PLC Holding(s) in Company
13/9/2019	16:40	UKREG	Futura Medical PLC Second Price Monitoring Extn
13/9/2019	16:35	UKREG	Futura Medical PLC Price Monitoring Extension
13/9/2019	11:46	UKREG	Futura Medical PLC Holding(s) in Company
12/9/2019	09:05	UKREG	Futura Medical PLC Second Price Monitoring Extn
12/9/2019	09:00	UKREG	Futura Medical PLC Price Monitoring Extension
11/9/2019	16:40	UKREG	Futura Medical PLC Second Price Monitoring Extn

More Futura Medical News

Futura Medical Takeover Rumours

Futura Medical (FUM) Share Charts

1 Year Futura Medical Chart

1 Month Futura Medical Chart

Intraday Futura Medical Chart

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date	Time	Title	Posts
16/10/2019	02:57	FUTURA a winner for 2015	6,150
08/7/2019	09:08	one million	2
21/1/2019	09:54	www.bluediamondcondom.com	59
02/12/2016	13:27	FUM delivering on sex,pain and rock'n'roll	11,414
21/6/2016	08:43	fum reality	1

Add a New Thread

Futura Medical (FUM) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
07:00:35	27.89	3,571	995.95	O
07:00:34	27.30	4,000	1,092.00	O
2019-10-15 15:12:06	27.63	10,539	2,912.35	O
2019-10-15 15:00:15	28.10	2,500	702.50	O
2019-10-15 14:57:43	28.10	10,676	2,999.95	O

View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

Date	Subject
15/10/2019 09:20	Futura Medical Daily Update: Futura Medical Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 27.50p. Futura Medical Plc has a 4 week average price of 26.75p and a 12 week average price of 26.50p. The 1 year high share price is 49p while the 1 year low share price is currently 5.50p. There are currently 204,660,267 shares in issue and the average daily traded volume is 930,734 shares. The market capitalisation of Futura Medical Plc is £57,304,874.76. Read Full Thread Reply
01/10/2019 12:19	j777j: My own view is the share price could reach Liberum's 60p price target upon news of completion of Phase 3 trials in a few days time. As this will be the most significant milestone in the company's history to date. If the trial results in december are a success the share price could head well over 100p.Liberum reckon 145p. Not long to wait. GLA to all patient holders. Read Full Thread Follow Reply
29/9/2019 20:28	duwendag: Thebutler and his alter ego Jonnybig should be reported as being one of the same, he must have a short on this stock as well with Iofin. He's Fxxked up on Iofina as their share price has doubled from 15p to 30p so lets hope the same happens with FUM. Theirs nothing wrong in a reasoned argument and discussion for or against a stock, but blatant lying to short a stock is despicable as he has done with Iofin and FUM, all I can say is "karma" Read Full Thread Follow Reply
12/9/2019 13:25	glavey: "According to Liberum a successful phase 3 will lead to a 95p share price..." Where do Liberum write that it will lead to a 95p share price? Read Full Thread Follow Reply
12/9/2019 11:47	j777j: According to Liberum a successful phase 3 will lead to a 95p share price and they will either do a deal and get funded for next stage or will be easy to raise money on the back of a phase 3 trial which is not a simple binary outcome,as they are many parts and ha s a high probablity of success as they are using a tried and tested drug.One that has an excellent safety profile over decades. They also point out that ex R&D costs are only around £1 million pa as it is an R&D co with low overheads and staff numbers. Read Full Thread Follow Reply
25/8/2019 15:09	tommyl1: I wonder if anyone would venture a guess as to what kind of share price FUM could sustain by virtue of TPR alone in the event that Med 2005 ph 3 results were not compelling enough to suit potential commercial partners. Of course there would be an initial bloodbath but for those that hang on long enough there will surely still be value. 30s? 20s? Read Full Thread Follow Reply
23/5/2019 12:16	loobrush: New broker -its good news as they can offer much more than previous one and will want toshow how they can do this and get the share price back to a sensible level. In my view some good news is due and they want the new broker to deal with this. Could well be approval for use of the pain products which is due anytime now. Rhat would give abig lift to the share price. Read Full Thread Follow Reply
09/1/2019 15:14	lbo: Such a fantastic opportunity that the partner who was supposedly in advanced discussions in March 2018 when the share price was 40p and then completely disappeared and now even at the supposed bargain of 10p has not reappeared with a bid. Never mind even buying shares in the 7p fundraising which was undersubscribed.Mr Barder then backtracked in September and October 2018 and said that raising funds and carrying out phase 3 would add 50% more value to the Med2002 licensing deal yet all the while the share price collapsed from 40p to 7p. So Futura management now need to add 400% in share price value to just get it back to the share price where they claimed they were in advanced discussions with a partner and then claimed by raising funds and completing phase 3 they would add 50% more value to the licensing deal. Read Full Thread Follow Reply
02/3/2018 15:12	j777j: Something for the weekend courtesy Gold dust on lse goldust881,179 posts Potential share price for Futura ? What is the future for Futura's share price. I have detailed below, from info in the results and more particularly from the webcast presentations what news Futura expects to announce during 2018, of which there is quite a lot that will affect the share price. MED2000-Securing of major commercial deal. CSD500-Reasignment of Rights for most of Europe and USA CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. So what about the share price. Clearly there is massive potential if all the products end up all on sale at once but leading up to that point I think that announcements of each of the above this year will increase the share price as each one will confirm that progress is being made, some more than others. Clearly with any deal being announced one can expect upfront deal fees which can be substantial and this is what Futura expect as they stated at the results seminar they have no need to raise further cash. Looking at other company deals in these sectors the total upfront fees could easily be in the ?25-40 million range. So what could Futura be worth in a couple of years time. From global sales figures provided by Futura we have the following potential for Futura's market share and earnings. MED 2000 ($1 billion per annum)= ?800 million say @5% royalty is ?40 million pa TPR100 & TIB200 (1/2 billion per annum)=?400 million say @5% royalty is ?20 million pa CSD500 @10% market share of a $6billion pa market is $600 million=?450 million @ 5% royalty rate is ?9 million per annum. That totals to ?69 million per annum. That's the potential. So with an income of that size with minimal overheads the company on a p/e of 10 % would be valued at ?690 million or ?5.56 per share Current company value @ 47p today is appx 57million So the potential is 10 times the current share price. With lots of news this year we could easily see the share price double up with the newsflow and a big bucks rise coming after the current MED 2000 trial results due shortly. News may come at any time so it's a buy at this price now in my view with results due out on 14th March. If any of one of these major deals comes of the share price would double.. Clearly another investor who has done the maths and sees a ten bagger from here. Read Full Thread Follow Reply
07/6/2017 09:33	mikethebike4: james 'There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here. - I have seen this written so many times over the last few years - I will be so shocked when it actually happens I will probably climax on the spot without the aid of Blue Diamond ! - 18 months product is already available from TTK in Asia - why they did not submit for regulatory approval at the same time in Europe I do not know - however I am expecting an announcement by the BoD so that the AGM is not a 'damp squib' MTB4 Read Full Thread Follow Reply
06/6/2017 22:59	jamesd888: There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here. Read Full Thread Follow Reply

Futura Medical share price data is direct from the London Stock Exchange

Your Recent History

LSE

FUM

Futura Med..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20191016 07:17:02